Skip to main content

Animations

MJFF Publications

1926 - 1950 of 9016 Results
Title
Year
  • Year
  • 2018
  • 2016
  • 2012
  • 2016
  • 2013
  • 2026
  • 2016
  • 2017
  • 2013
  • 2023
  • 2018
  • 2012
  • 2018
  • 2019
  • 2011
  • 2015
  • 2019
  • 2021
  • 2022
  • 2009
  • 2024
  • 2020
  • 2023
  • 2018
  • 2022
  • Summary Details
    OPEN
    Title: Subtype definition of vascular parkinsonism
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.03.005
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Neurogenesis in Cancun: where science meets the sea
    Journal Name: Development
    Publisher: The Company of Biologists
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1242/dev.138412
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Impact of L-DOPA treatment on regional cerebral blood flow and metabolism in the basal ganglia in a rat model of Parkinson's disease
    Journal Name: NeuroImage
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neuroimage.2012.02.066
    Citation Count: 77
  • Summary Details
    OPEN
    Title: Novel method to ascertain chromatin accessibility at specific genomic loci from frozen brain homogenates and laser capture microdissected defined cells
    Journal Name: Neuroepigenetics
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.nepig.2016.03.001
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Phosphoproteomic evaluation of pharmacological inhibition of leucine‐rich repeat kinase 2 reveals significant off‐target effects of LRRK‐2‐IN‐1
    Journal Name: Journal of Neurochemistry
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1111/jnc.12483
    Citation Count: 66
  • Summary Details
    OPEN
    Title: A Holistic Approach to Identifying a Positron Emission Tomography (PET) Tracer Candidate for In Vivo Imaging of Purinergic P2X7 Receptor in Neuroinflammation
    Journal Name: ACS Pharmacology & Translational Science
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1021/acsptsci.5c00820
    Citation Count: 0
  • Summary Details
    OPEN
    Title: α‐synuclein genetic variability: A biomarker for dementia in Parkinson disease
    Journal Name: Annals of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/ana.24664
    Citation Count: 98
  • Summary Details
    OPEN
    Title: A high-resolution map of the human small non-coding transcriptome
    Journal Name: Bioinformatics
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/bioinformatics/btx814
    Citation Count: 28
  • Summary Details
    RESTRICTED
    Title: Decreased parvalbumin mRNA expression in dorsolateral prefrontal cortex in Parkinson′s disease
    Journal Name: Brain Research
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.brainres.2013.07.025
    Citation Count: 33
  • The Hypoxia Response Pathway: A Potential Intervention Target in Parkinson's Disease?
    2023
    Summary Details
    OPEN
    Title: The Hypoxia Response Pathway: A Potential Intervention Target in Parkinson's Disease?
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.29688
    Citation Count: 11
  • PDE10A and ADCY5 mutations linked to molecular and microstructural basal ganglia pathology
    2018
    Summary Details
    RESTRICTED
    Title: PDE10A and ADCY5 mutations linked to molecular and microstructural basal ganglia pathology
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.27523
    Citation Count: 46
  • Summary Details
    RESTRICTED
    Title: Daytime alertness in Parkinson's disease: Potentially dose‐dependent, divergent effects by drug class
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.25082
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Predicting alpha-synuclein pathology by REM sleep behavior disorder diagnosis
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.05.020
    Citation Count: 28
  • Summary Details
    OPEN
    Title: Parafoveal thinning of inner retina is associated with visual dysfunction in Lewy body diseases
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mds.27728
    Citation Count: 49
  • Cognitive dysfunction in Tunisian LRRK2 associated Parkinson’s disease
    2011
    Summary Details
    RESTRICTED
    Title: Cognitive dysfunction in Tunisian LRRK2 associated Parkinson’s disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2011.10.009
    Citation Count: 48
  • Summary Details
    OPEN
    Title: Ceruloplasmin functional changes in Parkinson’s disease-cerebrospinal fluid
    Journal Name: Molecular Neurodegeneration
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s13024-015-0055-2
    Citation Count: 45
  • Summary Details
    OPEN
    Title: Complementary motivational roles of nigroaccumbens and nigrostriatal dopaminergic pathways
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.27504
    Citation Count: 4
  • Transcriptome-wide Association Study in Frontotemporal Dementia Identifies New Disease Loci by In Silico Analysis
    2021
    Summary Details
    RESTRICTED
    Title: Transcriptome-wide Association Study in Frontotemporal Dementia Identifies New Disease Loci by In Silico Analysis
    Journal Name: Biological Psychiatry
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.biopsych.2021.02.010
    Citation Count: 0
  • Summary Details
    OPEN
    Title: A Phosphosite Mutant Approach on LRRK2 Links Phosphorylation and Dephosphorylation to Protective and Deleterious Markers, Respectively
    Journal Name: Cells
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/cells11061018
    Citation Count: 6
  • Summary Details
    OPEN
    Title: No evidence for cognitive dysfunction or depression in patients with mild restless legs syndrome
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.22701
    Citation Count: 75
  • Summary Details
    OPEN
    Title: Die Vermehrung von Alpha‐Synuclein Amyloidfibrillen ist unterdrückt unter vollständig ruhenden Lösungsbedingungen
    Journal Name: Angewandte Chemie
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1002/ange.202419173
    Citation Count: 0
  • Pharmacokinetics and Biomarker Changes in NILO-PD, A Phase 2A Study of Nilotinib in Patients with Moderate to Advance Parkinson’s Disease (4418)
    2020
    Summary Details
    RESTRICTED
    Title: Pharmacokinetics and Biomarker Changes in NILO-PD, A Phase 2A Study of Nilotinib in Patients with Moderate to Advance Parkinson’s Disease (4418)
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.94.15_supplement.4418
    Citation Count: 1
  • Summary Details
    OPEN
    Title: A Fixable Fluorescence‐Quenched Substrate for Quantitation of Lysosomal Glucocerebrosidase Activity in Both Live and Fixed Cells
    Journal Name: Angewandte Chemie
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/ange.202309306
    Citation Count: 1
  • Summary Details
    RESTRICTED
    Title: Genetic variants related to urate and risk of Parkinson's disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: other-oa
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.04.031
    Citation Count: 7
  • Summary Details
    OPEN
    Title: Multi-transcriptomic analysis points to early organelle dysfunction in human astrocytes in Alzheimer's disease
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.nbd.2022.105655
    Citation Count: 88
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.